Metabolic myopathy presenting with polyarteritis nodosa: a case report
Open Access
- 30 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Medical Case Reports
- Vol. 5 (1), 262
- https://doi.org/10.1186/1752-1947-5-262
Abstract
Introduction To the best of our knowledge, we describe for the first time a patient in whom an unusual metabolic myopathy was identified after failure to respond to curative therapy for a systemic vasculitis, polyarteritis nodosa. We hope this report will heighten awareness of common metabolic myopathies that may present later in life. It also speculates on the potential relationship between metabolic myopathy and systemic vasculitis. Case presentation A 78-year-old African-American woman with a two-year history of progressive fatigue and exercise intolerance presented to our facility with new skin lesions and profound muscle weakness. Skin and muscle biopsies demonstrated a medium-sized artery vasculitis consistent with polyarteritis nodosa. Biochemical studies of the muscle revealed diminished cytochrome C oxidase activity (0.78 μmol/minute/g tissue; normal range 1.03 to 3.83 μmol/minute/g tissue), elevated acid maltase activity (23.39 μmol/minute/g tissue; normal range 1.74 to 9.98 μmol/minute/g tissue) and elevated neutral maltase activity (35.89 μmol/minute/g tissue; normal range 4.35 to 16.03 μmol/minute/g tissue). Treatment for polyarteritis nodosa with prednisone and cyclophosphamide resulted in minimal symptomatic improvement. Additional management with a diet low in complex carbohydrates and ubiquinone, creatine, carnitine, folic acid, α-lipoic acid and ribose resulted in dramatic clinical improvement. Conclusions Our patient's initial symptoms of fatigue, exercise intolerance and progressive weakness were likely related to her complex metabolic myopathy involving both the mitochondrial respiratory chain and glycogen storage pathways. Management of our patient required treatment of both the polyarteritis nodosa as well as metabolic myopathy. Metabolic myopathies are common and should be considered in any patient with exercise intolerance. Metabolic myopathies may complicate the management of various disease states.Keywords
This publication has 18 references indexed in Scilit:
- Mitochondrial pathology in immune and inflammatory myopathiesCurrent Opinion in Rheumatology, 2010
- Metabolic myopathies: the challenge of new treatmentsCurrent Opinion in Pharmacology, 2010
- Mitochondrial DNA mutations in disease and agingEnvironmental and Molecular Mutagenesis, 2010
- A Diagnostic Algorithm for Metabolic MyopathiesCurrent Neurology and Neuroscience Reports, 2010
- Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish casesClinical Neuropathology, 2009
- The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathiesAdvanced Drug Delivery Reviews, 2008
- Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative DiseasesNeuroMolecular Medicine, 2008
- Metabolic myopathies: a guide and update for cliniciansCurrent Opinion in Rheumatology, 2008
- Thyroid Hormone Effects on Mitochondrial EnergeticsThyroid®, 2008
- Vascularites associées aux infections viralesLa Presse Médicale, 2004